Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer is a research paper published in Gastroenterology (2022). On theSindex it has a DataRank of 3.5. It has been cited 164 times, with 150 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.766
From this paper's citation signal
Citation Network Contribution
2.8
From 120 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 150 citers.
National Institutes of Health
Grant: P30CA240139
Association for Academic Surgery
Grant: R21CA209536
National Cancer Institute
Grant: T32CA211034
National Cancer Institute
Grant: 2R01CA161976
American Association for Cancer Research
Grant: 15-65-25-MER
American Cancer Society
Grant: IRG 98-277-13
NCI NIH HHS
Grant: R01 CA161976
NCATS NIH HHS
Grant: UL1 TR002736
NCI NIH HHS
Grant: R01 CA262526
Miami Clinical and Translational Science Institute, University of Miami
Sylvester Comprehensive Cancer Center
American College of Surgeons
FWCI
10.82
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Polyphyllin I exerts anti-hepatocellular carcinoma activity by targeting ZBTB16 to activate the PPARγ/RXRα signaling pathway
Additional file 1 of Polyphyllin I exerts anti-hepatocellular carcinoma activity by targeting ZBTB16 to activate the PPARγ/RXRα signaling pathway